Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

LASTACAFT ONCE DAILY 0.25% DRP

alcaftadine
$2.8402per ML
OTC

Strength

2.5 mg/mL

Manufacturer

Allergan, Inc.

NDC

00023429105

Classification

Brand

Dosage Form

SOLUTION/ DROPS

Route

OPHTHALMIC

Last Updated

3/18/2026

Active Ingredients

ALCAFTADINE

Approval Type

New Drug (NDA)

FDA Application

NDA022134

On Market Since

12/1/2021

Pharmacological Classes

Histamine H1 Receptor Antagonists
Histamine-1 Receptor Antagonist

Price History

1W

0.0%

1M

0.0%

3M

+0.2%

6M

+0.1%

1Y

-0.1%

3Y

N/A

5Y

N/A

All

+0.7%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

ZZZQUIL 50 MG/30 ML LIQUID
Brand
37000050012•The Procter & Gamble Manufacturing Company
$0.0204
per ML
THERAFLU EXPRESSMAX COLD NT LQ
Brand
00067812908•Haleon US Holdings LLC
$0.0221
per ML
ZZZQUIL 50 MG/30 ML LIQUID
Brand
37000050006•The Procter & Gamble Manufacturing Company
$0.0236
per ML
ROBITUSSIN LONG-ACTING LIQ
Brand
00031869312•Haleon US Holdings LLC
$0.0375
per ML
ADVIL PM CAPLET
Brand
00573016405•Haleon US Holdings LLC
$0.1651
per EA
ADVIL PM CAPLET
Brand
00573016420•Haleon US Holdings LLC
$0.1651
per EA
ADVIL PM CAPLET
Brand
00573016430•Haleon US Holdings LLC
$0.1651
per EA
ADVIL PM CAPLET
Brand
00573016440•Haleon US Holdings LLC
$0.1651
per EA
ADVIL PM CAPLET
Brand
00573016443•Haleon US Holdings LLC
$0.1651
per EA
ADVIL PM LIQUI-GELS
Brand
00573016725•Haleon US Holdings LLC
$0.1985
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy